On May 12, ADVI Health’s head of policy, research, and analysis, Lindsay Bealor Greenleaf, sat down with Health Payer Specialist to discuss President Trump’s Executive Order on drug pricing negotiations.

In the article, “Cigna, CVS Shares Crater Amid Potential Regulatory Assault,” Lindsay discusses how the issue appears to apply to all markets, including Medicare, Medicaid, and the commercial market.

Read more in Health Payer Specialist.